Peptide exchange–competent class I MHC molecules produced in eukaryotic cells for rapid production of MHC multimers

V Vasanthi Ramachandiran (Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,) J John C Shires (Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,) R Richard A Willis (Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,) G Ge Bai D Donielle L Bell (Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,) L Lixia Han T Tamara R Kazarian (Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,) F Fred O Ede (Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,) O Oskar Laur S Sujin Lee D Dale L Long (Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,) J John D Altman (Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,)

Abstract

Abstract Class I MHC peptide (MHC-Ip) multimers are well-established reagents that detect antigen-specific T cells. The classical method for production of MHC-Ip multimers begins with the expression of MHC heavy chains (HCs) and β2-microglobulin (β2m) subunits as inclusion bodies in Escherichia coli and is followed by denaturant solubilization, in vitro folding in the presence of a defined peptide ligand, and purification by size exclusion chromatography. This protocol is labor intensive, difficult to scale, and represents a significant bottleneck in application of the technology. Herein, we present a novel method for the expression in eukaryotic cells of secreted peptide exchange–competent class I MHC proteins in their native conformation. In this method, expression constructs are engineered as bimolecular complexes composed of an MHC HC and a β2m molecule covalently linked at its amino terminus to an MHC-binding peptide through a flexible peptide linker containing a defined protease site. Upon proteolysis, the original peptide occupant of the MHC binding site dissociates and is easily replaced with a synthetic peptide. When leucine zippers are added to the carboxyl terminus of each subunit, protease cleavage of the linker results in a stable HC/β2m complex that can be isolated and stored for subsequent peptide loading. Using this method, we have produced homogeneous MHC-Ip complexes for 25 class I MHC alleles and demonstrated that tetramers produced in this way are equivalent to conventionally produced tetramers for T-cell staining.

Article Details

Volume / Issue Vol. 215, Issue 8
Published August 04, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (12)

V

Vasanthi Ramachandiran

Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,

J

John C Shires

Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,

R

Richard A Willis

Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,

G

Ge Bai

D

Donielle L Bell

Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,

L

Lixia Han

T

Tamara R Kazarian

Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,

F

Fred O Ede

Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,

O

Oskar Laur

S

Sujin Lee

D

Dale L Long

Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,

J

John D Altman

Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,